Health Care insider trading activity
In the last 30 days, insiders at 347 Health Care companies reported 208 purchases worth $168.88M and 1,037 sales worth $1.60B. Below, the companies are ranked by how many insiders filed.
Most-active companies
200Showing companies 151 to 200 of 200 by distinct insiders filing.
| # | Ticker / Company | Insiders (30d) | Insider buys (30d) |
|---|---|---|---|
| 151 |  $IRON Disc Medicine, Inc. | 1 | - |
| 152 |  $REGN REGENERON PHARMACEUTICALS, INC. | 1 | - |
| 153 |  $PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 1 | - |
| 154 |  $CRBP Corbus Pharmaceuticals Holdings, Inc. | 1 | - |
| 155 |  $LGND LIGAND PHARMACEUTICALS INC | 1 | - |
| 156 |  $TENX TENAX THERAPEUTICS, INC. | 1 | $1.46M |
| 157 |  $PLUR Pluri Inc. | 1 | $1.25M |
| 158 |  $BEAM Beam Therapeutics Inc. | 1 | - |
| 159 |  $IDYA IDEAYA Biosciences, Inc. | 1 | - |
| 160 |  $KRRO Korro Bio, Inc. | 1 | $885K |
| 161 |  $OM Outset Medical, Inc. | 1 | $870K |
| 162 |  $INBX Inhibrx Biosciences, Inc. | 1 | $849K |
| 163 |  $AMLX Amylyx Pharmaceuticals, Inc. | 1 | - |
| 164 |  $TNGX Tango Therapeutics, Inc. | 1 | - |
| 165 |  $ACOG Alpha Cognition Inc. | 1 | $574K |
| 166 |  $CNXU Conexeu Sciences Inc. | 1 | $500K |
| 167 |  $OCGN Ocugen, Inc. | 1 | - |
| 168 |  $CTMX CytomX Therapeutics, Inc. | 1 | - |
| 169 |  $HCSG HEALTHCARE SERVICES GROUP INC | 1 | - |
| 170 |  $GRCE Grace Therapeutics, Inc. | 1 | $456K |
| 171 |  $BIOE Bio Essence Corp | 1 | - |
| 172 |  $RVMD Revolution Medicines, Inc. | 1 | - |
| 173 |  $BOLD Boundless Bio, Inc. | 1 | $427K |
| 174 |  $ALNY ALNYLAM PHARMACEUTICALS, INC. | 1 | - |
| 175 |  $AGIO AGIOS PHARMACEUTICALS, INC. | 1 | - |
| 176 |  $ZYME Zymeworks Inc. | 1 | - |
| 177 |  $ANGO ANGIODYNAMICS INC | 1 | - |
| 178 |  $ALHC Alignment Healthcare, Inc. | 1 | - |
| 179 |  $GKOS GLAUKOS Corp | 1 | - |
| 180 |  $MAZE Maze Therapeutics, Inc. | 1 | - |
| 181 |  $RPRX Royalty Pharma plc | 1 | - |
| 182 |  $ETON Eton Pharmaceuticals, Inc. | 1 | - |
| 183 |  $ZVRA ZEVRA THERAPEUTICS, INC. | 1 | - |
| 184 |  $PCRX Pacira BioSciences, Inc. | 1 | - |
| 185 |  $HIMS Hims & Hers Health, Inc. | 1 | - |
| 186 |  $ORIC Oric Pharmaceuticals, Inc. | 1 | - |
| 187 |  $SEPN Septerna, Inc. | 1 | - |
| 188 |  $SNDX Syndax Pharmaceuticals Inc | 1 | - |
| 189 |  $RARE Ultragenyx Pharmaceutical Inc. | 1 | - |
| 190 |  $INM InMed Pharmaceuticals Inc. | 1 | $86K |
| 191 |  $STSS Sharps Technology Inc. | 1 | $78K |
| 192 |  $UTMD UTAH MEDICAL PRODUCTS INC | 1 | $67K |
| 193 |  $NXTC NextCure, Inc. | 1 | $54K |
| 194 |  $STIM Neuronetics, Inc. | 1 | $41K |
| 195 |  $ELTP ELITE PHARMACEUTICALS INC | 1 | $26K |
| 196 |  $OTLC Oncotelic Therapeutics, Inc. | 1 | $24K |
| 197 |  $AIM AIM ImmunoTech Inc. | 1 | $10K |
| 198 |  $XAIR Beyond Air, Inc. | 1 | $6K |
| 199 |  $CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | 1 | $653 |
| 200 |  $BCDA BioCardia, Inc. | 1 | $475 |
Industries in this sector
10- Pharmaceutical Preparations - 152 companies
- Biological Products, (No Diagnostic Substances) - 63 companies
- Surgical & Medical Instruments & Apparatus - 44 companies
- Services-Medical Laboratories - 13 companies
- Electromedical & Electrotherapeutic Apparatus - 11 companies
- Services-Commercial Physical & Biological Research - 8 companies
- Orthopedic, Prosthetic & Surgical Appliances & Supplies - 8 companies
- Hospital & Medical Service Plans - 7 companies
- Laboratory Analytical Instruments - 6 companies
- In Vitro & In Vivo Diagnostic Substances - 6 companies
Reading a sector
Sales usually dwarf purchases, and that is normal, not a warning. Executives are paid in stock. They sell to diversify and to pay the tax due when awards vest, so a big sell total across a sector mostly reflects a vesting calendar. Purchases are the rarer side, because each one is an insider choosing to add to a company they already know well.
The table ranks companies by how many different insiders filed, not by dollars. That puts the cluster case near the top: several people inside one business acting in the same month. Sector placement comes from each company's SEC SIC code, mapped to the GICS sectors through a standard crosswalk, with manual fixes for well-known names the SIC code gets wrong. A single company can still land in a different sector than an index provider would give it.